Robert W. Baird restated their hold rating on shares of Stericycle (NASDAQ:SRCL) in a research report released on Tuesday.

“Driven by the successful turnaround efforts at Terminix and solid performance in FSG, adjusted EBITDA of $105M was in line with our estimate and beat the Street’s $101M estimate; revenues of $496M also beat our/Street’s $489M/$486M estimates. Management raised FY2018 revenue guidance to $1,885-1,900M ($1,875M-$1,890M previously), owing to the transformation efforts and performance of acquisitions at Terminix. The company reiterated adjusted EBITDA guidance of $425-435M, as it continues to invest in the business to create sustainable, long-term growth. Maintain Outperform.”,” Robert W. Baird’s analyst commented.

Several other research analysts also recently commented on the company. BMO Capital Markets reduced their price objective on Stericycle from $58.00 to $51.00 and set a market perform rating on the stock in a report on Tuesday. Bank of America reduced their price objective on Stericycle from $53.00 to $50.00 and set an underperform rating on the stock in a report on Friday, November 2nd. Northcoast Research restated a neutral rating on shares of Stericycle in a report on Friday, October 12th. Zacks Investment Research downgraded Stericycle from a hold rating to a sell rating in a report on Tuesday, October 9th. Finally, Barrington Research set a $72.00 price objective on Stericycle and gave the stock a buy rating in a report on Friday, October 5th. Five research analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus price target of $65.38.

SRCL traded down $0.20 during trading on Tuesday, hitting $47.66. 1,229,511 shares of the stock were exchanged, compared to its average volume of 1,264,153. The company has a market capitalization of $4.40 billion, a P/E ratio of 10.98, a PEG ratio of 1.26 and a beta of 0.52. Stericycle has a 1 year low of $45.55 and a 1 year high of $76.73. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.93.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, November 1st. The business services provider reported $1.03 EPS for the quarter, topping the consensus estimate of $1.01 by $0.02. The company had revenue of $854.90 million for the quarter, compared to the consensus estimate of $856.36 million. Stericycle had a return on equity of 13.74% and a net margin of 4.63%. Stericycle’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period last year, the business posted $1.10 EPS. Equities analysts anticipate that Stericycle will post 4.38 earnings per share for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Whittier Trust Co. boosted its position in Stericycle by 362.6% during the 2nd quarter. Whittier Trust Co. now owns 1,087 shares of the business services provider’s stock valued at $129,000 after acquiring an additional 852 shares in the last quarter. Zions Bancorporation bought a new stake in Stericycle during the 3rd quarter valued at $130,000. Dupont Capital Management Corp boosted its position in Stericycle by 102.2% during the 2nd quarter. Dupont Capital Management Corp now owns 2,089 shares of the business services provider’s stock valued at $136,000 after acquiring an additional 1,056 shares in the last quarter. Pflug Koory LLC boosted its position in Stericycle by 106.6% during the 3rd quarter. Pflug Koory LLC now owns 2,810 shares of the business services provider’s stock valued at $165,000 after acquiring an additional 1,450 shares in the last quarter. Finally, NumerixS Investment Technologies Inc boosted its position in Stericycle by 285.0% during the 2nd quarter. NumerixS Investment Technologies Inc now owns 2,695 shares of the business services provider’s stock valued at $174,000 after acquiring an additional 1,995 shares in the last quarter. 95.11% of the stock is currently owned by institutional investors and hedge funds.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

Read More: What is a stock buyback?

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.